LEADER 7: cardiovascular risk profiles of US and European participants in the LEADER diabetes trial differ

AIMS: To determine whether US and European participants in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results (LEADER) trial differ regarding risk factors for cardiovascular mortality and morbidity. METHODS: Baseline data, stratified for prior cardiovascular...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutten, Guy E. H. M., Tack, Cees J., Pieber, Thomas R., Comlekci, Abdurrahman, Ørsted, David Dynnes, Baeres, Florian M. M., Marso, Steven P., Buse, John B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891842/
https://www.ncbi.nlm.nih.gov/pubmed/27274772
http://dx.doi.org/10.1186/s13098-016-0153-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891842/
https://www.ncbi.nlm.nih.gov/pubmed/27274772
http://dx.doi.org/10.1186/s13098-016-0153-5

Ejemplares similares